Fractyl Health (GUTS) Net Cash Flow (2023 - 2026)

Fractyl Health (GUTS) has reported Net Cash Flow for 4 consecutive years, with -$16.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow rose 19.12% year-over-year to -$16.0 million; the trailing twelve-month figure through Jun 2026 stood at $24.8 million (up 130.88% YoY), and the FY2025 full-year result was $14.1 million, down 58.53% from the prior year.
• Net Cash Flow was -$16.0 million for Q2 2026 at Fractyl Health, up from -$18.4 million in the prior quarter.
• The five-year high for Net Cash Flow was $88.2 million in Q1 2024, with the low at -$25.4 million in Q1 2025.
• Historically, Net Cash Flow has averaged -$152071.4 across 4 years, with a median of -$13.9 million in 2023.
• On a YoY basis, Net Cash Flow climbed as much as 1021.77% in 2024 and fell as far as 207.67% in 2024.
• Tracing GUTS's Net Cash Flow over 4 years: stood at -$11.3 million in 2023, then tumbled by 52.33% to -$17.2 million in 2024, then jumped by 122.58% to $3.9 million in 2025, then sank by 512.77% to -$16.0 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$16.0 million in Q2 2026, -$18.4 million in Q1 2026, and $3.9 million in Q4 2025.